News and Announcements
Mobilicom Limited’s (ASX: MOB) Strong Q2 2018 Results
- Published August 03, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Mobilicom outperforms expected business goals for Q2.
- The company had strong financial improvements with a strong cash balance of $6.6m.
- The company completed two successful proof of concept trials, two design wins, secured two new partnerships and launched their SkyHopper ControlAir.
MobilicomQ2 Activities report has seen significant financial improvements over vital parameters. This past quarter has seen Mobilicom conduct two successful proof of concept trials by their Mobilico Communication Units (MCUs) in Sri Lanka and the Czech Republic. The company exceeded their first-year plans with ten design wins, obtaining three certifications across the US, Europe and Japan, and the launching of five products. The 2018 Q2 saw the company improve their financial results with cash receipts up 13% from Q1 2018. Operating expenses were lower than expected to allow the company to maintain a healthy cash balance of $6.6m.
Mobilicom secured two new design wins in Q2. The first with UK-based Clogworks Technologies, manufacturer of unmanned aerial vehicles for security and surveillance application. The second, Percepto, an Israeli autonomous drone manufacturer. Mobilicom established partnerships with Japan UAS industrial Development Association (JUIDA) and the Israeli company, Agrowing. This quarter, the company released their SkyHopper Control Air, a mobile controller for commercial and industrial drones. The release makes the company a step further to becoming an end-to-end provider in the drones and robotics market.
About Mobilicom Limited (ASX: MOB)
Mobilicom designs, develops and markets solutions for mission critical and remote mobile private communication networks without the need for, or use of, any existing infrastructure. Mobilicom’s products and technology merge 4G communication with Mobile MESH technologies into a unified solution, with several product families that have been commercially deployed. Mobilicom’s SkyHopper entity targets the Professional, Commercial and Industrial UAV market.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
